Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 07, 2023

SELL
$212.99 - $276.17 $638 - $828
-3 Closed
0 $0
Q2 2022

Nov 07, 2023

SELL
$174.81 - $241.14 $874 - $1,205
-5 Reduced 62.5%
3 $707,000
Q1 2022

Nov 07, 2023

BUY
$166.16 - $213.96 $498 - $641
3 Added 60.0%
8 $1.44 Million
Q4 2021

Nov 07, 2023

BUY
$184.32 - $216.08 $921 - $1,080
5 New
5 $1.08 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.